A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Completed · Phase 3 · Has a placebo group

Conditions studied: Macular Edema, Retinal Vein Occlusion

In brief

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of macular edema associated with retinal vein occlusion.

Key facts

Study ID

NCT00168298

Run by

Allergan

People needed

668

Starts

2004-11-01

Expected to finish

2008-09-05

Last updated by the study team

2019-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Houston, Texas, United States
• Study site — São Paulo, Brazil
• Study site — Mississauga, Ontario, Canada
• Study site — Bogotá, Colombia
• Study site — Kowloon, Hong Kong
• Study site — Tamil Nadu, India
• Study site — Udine, Italy
• Study site — Auckland, New Zealand
• Study site — Poznan, Poland
• Study site — Singapore, Singapore
• Study site — Seoul, South Korea
• Study site — Alicante, Spain
• Study site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.